1. Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine- on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis. Issue 2 (17th December 2021) Authors: Grosu, Oxana; Yamani, Nooshin; Schuster, Nathaniel; Sreedharan, Jayadevan; Berchan, Joelle; Pradeep, Manu; Riahi, Anis; Thomas, Pravin Journal: Headache medicine connections Issue: Volume 1:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗